Johnson & Johnson [JNJ] fell -14.58% so far this year. What now?

- Advertisements -

Johnson & Johnson [NYSE: JNJ] loss -0.53% on the last trading session, reaching $150.90 price per share at the time. The company report on October 23, 2023 at 4:15 PM that Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech.

Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities. Ms. McEvoy will remain with the Company into Q1 2024 to support a successful transition. Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company’s Executive Committee.

- Advertisements -

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Ms. McEvoy joined Johnson & Johnson 27 years ago in the Consumer Products Group, where she oversaw classic brands including Tylenol® and Zyrtec® and grew her career to serve as President of McNeil Consumer Healthcare. Ms. McEvoy moved to MedTech in 2009 where she served as Worldwide President of Ethicon and then advanced to become Company Group Chairman of Vision and Diabetes Care prior to assuming her current role. Ms. McEvoy is presently serving as chair of the AdvaMed board of directors, the leading global trade association and consortium of companies for the medical devices industry and also serves on the Board of Trustees for the Children’s Hospital of Philadelphia (CHOP).

Johnson & Johnson represents 2.61 billion in outstanding shares, while the company has a total market value of $363.26 billion with the latest information. JNJ stock price has been found in the range of $150.68 to $152.25.

- Advertisements -

If compared to the average trading volume of 20.53M shares, JNJ reached a trading volume of 4840186 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Johnson & Johnson [JNJ]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $175.95 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

RBC Capital Mkts have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on October 05, 2023.

- Advertisements -

The Average True Range (ATR) for Johnson & Johnson is set at 2.18, with the Price to Sales ratio for JNJ stock in the period of the last 12 months amounting to 3.81. The Price to Book ratio for the last quarter was 5.10, with the Price to Cash per share for the same quarter was set at 9.77. Price to Free Cash Flow for JNJ in the course of the last twelve months was 23.08 with Quick ratio for the last quarter at 0.96.

Trading performance analysis for JNJ stock

Johnson & Johnson [JNJ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.73. With this latest performance, JNJ shares dropped by -4.82% in over the last four-week period, additionally sinking by -6.30% over the last 6 months – not to mention a drop of -12.00% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JNJ stock in for the last two-week period is set at 42.70, with the RSI for the last a single of trading hit 46.95, and the three-weeks RSI is set at 41.03 for Johnson & Johnson [JNJ]. The present Moving Average for the last 50 days of trading for this stock 156.79, while it was recorded at 150.57 for the last single week of trading, and 160.55 for the last 200 days.

Johnson & Johnson [JNJ]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Johnson & Johnson [JNJ] shares currently have an operating margin of +26.08 and a Gross Margin at +67.67. Johnson & Johnson’s Net Margin is presently recorded at +18.88.

Return on Total Capital for JNJ is now 21.88, given the latest momentum, and Return on Invested Capital for the company is 17.09. Return on Equity for this stock inclined to 23.79, with Return on Assets sitting at 9.71. When it comes to the capital structure of this company, Johnson & Johnson [JNJ] has a Total Debt to Total Equity ratio set at 53.33. Additionally, JNJ Total Debt to Total Capital is recorded at 34.78, with Total Debt to Total Assets ending up at 21.86. Long-Term Debt to Equity for the company is recorded at 36.70, with the Long-Term Debt to Total Capital now at 23.94.

Reflecting on the efficiency of the workforce at the company, Johnson & Johnson [JNJ] managed to generate an average of $117,492 per employee. Receivables Turnover for the company is 6.04 with a Total Asset Turnover recorded at a value of 0.51.Johnson & Johnson’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.96 and a Current Ratio set at 1.21.

Johnson & Johnson [JNJ]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 5.20%.

An analysis of Institutional ownership at Johnson & Johnson [JNJ]

The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2579%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $201.66 billion in JNJ stocks shares; and BERKSHIRE HATHAWAY INC, currently with $177.59 billion in JNJ stock with ownership which is approximately 5.7994%.

- Advertisements -

Leave a Reply

Your email address will not be published. Required fields are marked *